{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:33:36Z","timestamp":1793338416247,"version":"4.5.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008431","name":"Junta de Castilla y Le\u00f3n Consejer\u00eda de Educaci\u00f3n","doi-asserted-by":"publisher","award":["CLU-2023-1-04"],"award-info":[{"award-number":["CLU-2023-1-04"]}],"id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CLU-2023-1-04"],"award-info":[{"award-number":["CLU-2023-1-04"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["VA168P18"],"award-info":[{"award-number":["VA168P18"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014180","name":"Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CB06\/01\/1028"],"award-info":[{"award-number":["CB06\/01\/1028"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CB06\/01\/003"],"award-info":[{"award-number":["CB06\/01\/003"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["MICIU\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MICIU\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2019-105525RB-100"],"award-info":[{"award-number":["PID2019-105525RB-100"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Government of the Basque Country","doi-asserted-by":"publisher","award":["Grupos Consolidados IT1448-22"],"award-info":[{"award-number":["Grupos Consolidados IT1448-22"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005053","name":"CIBER-BBN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115305","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:50:39Z","timestamp":1787669439000},"page":"115305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["Nano-engineered mesenchymal stem cells as a platform for targeted and biologically regulated drug delivery in ocular surface inflammation"],"prefix":"10.1016","volume":"399","author":[{"given":"Idoia","family":"Gallego","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Marce\u00f1ido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Ciriza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Galindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"L\u00f3pez-Paniagua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"de la Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Puras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Calonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Pedraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Nieto-Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115305_bb0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1083\/jcb.103.1.49","article-title":"Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells","volume":"103","author":"Schermer","year":"1986","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115305_bb0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jtos.2015.12.002","article-title":"Niche regulation of limbal epithelial stem cells: relationship between inflammation and regeneration","volume":"14","author":"Tseng","year":"2016","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.jconrel.2026.115305_bb0015","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3390\/pharmaceutics13091483","article-title":"Goals and challenges of stem cell-based therapy for corneal blindness due to limbal deficiency","volume":"13","author":"Calonge","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115305_bb0020","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/ICO.0000000000001820","article-title":"Global consensus on definition, classification, diagnosis, and staging of limbal stem cell deficiency","volume":"38","author":"Deng","year":"2019","journal-title":"Cornea"},{"key":"10.1016\/j.jconrel.2026.115305_bb0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.trsl.2018.11.003","article-title":"A proof-of-concept clinical trial using mesenchymal stem cells for the treatment of corneal epithelial stem cell deficiency","volume":"206","author":"Calonge","year":"2019","journal-title":"Transl. Res."},{"key":"10.1016\/j.jconrel.2026.115305_bb0030","series-title":"Corneal Regeneration. Essentials in Ophthalmology","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-3-030-01304-2_17","article-title":"Cell therapy using extraocular mesenchymal stem cells","author":"Nieto-Miguel","year":"2019"},{"key":"10.1016\/j.jconrel.2026.115305_bb0035","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/14712598.2019.1607836","article-title":"Mesenchymal stromal cells for ocular surface repair","volume":"19","author":"Al-Jaibaji","year":"2019","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2026.115305_bb0040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/02713683.2019.1639765","article-title":"Limbal epithelial and mesenchymal stem cell therapy for corneal regeneration","volume":"45","author":"Shukla","year":"2020","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2026.115305_bb0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/ICO.0b013e3181e2d0f5","article-title":"Management of focal limbal stem cell deficiency associated with soft contact lens wear","volume":"30","author":"Jeng","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.jconrel.2026.115305_bb0050","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00417-002-0581-9","article-title":"Efficacy of indomethacin 0.1% and fluorometholone 0.1% on conjunctival inflammation following chronic application of antiglaucomatous drugs","volume":"240","author":"Baudouin","year":"2002","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jconrel.2026.115305_bb0055","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/ICO.0000000000000695","article-title":"Comparison of the efficacy of fluorometholone with and without benzalkonium chloride in ocular surface disease","volume":"35","author":"Kim","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.jconrel.2026.115305_bb0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/pharmaceutics10040208","article-title":"Development and evaluation of a water soluble fluorometholone eye drop formulation employing polymeric micelle","volume":"10","author":"Noh","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115305_bb0065","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijpharm.2018.05.050","article-title":"Development of fluorometholone-loaded PLGA nanoparticles for treatment of inflammatory disorders of anterior and posterior segments of the eye","volume":"547","author":"Gonzalez-Pizarro","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115305_bb0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.colsurfb.2018.11.065","article-title":"In-situ forming gels containing fluorometholone-loaded polymeric nanoparticles for ocular inflammatory conditions","volume":"175","author":"Gonzalez-Pizarro","year":"2019","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2026.115305_bb0075","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.2217\/nnm-2019-0201","article-title":"Ocular penetration of fluorometholone-loaded PEG-PLGA nanoparticles functionalized with cell-penetrating peptides","volume":"14","author":"Gonzalez-Pizarro","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115305_bb0080","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/pharmaceutics12030288","article-title":"Nanostructured lipid carriers for delivery of chemotherapeutics: a review","volume":"12","author":"Haider","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115305_bb0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nano.2015.09.004","article-title":"Nanostructured lipid carriers: promising drug delivery systems for future clinics","volume":"12","author":"Beloqui","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115305_bb0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejpb.2016.10.015","article-title":"Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues","volume":"109","author":"Balguri","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2026.115305_bb0095","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/22\/4\/045101","article-title":"Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery","volume":"22","author":"Gonzalez-Mira","year":"2011","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jconrel.2026.115305_bb0100","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/jps.22813","article-title":"Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery","volume":"101","author":"Tian","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115305_bb0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.colsurfb.2012.08.021","article-title":"Further investigation of nanostructured lipid carriers as an ocular delivery system: in vivo transcorneal mechanism and in vitro release study","volume":"102","author":"Tian","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2026.115305_bb0110","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drudis.2012.10.005","article-title":"Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers","volume":"18","author":"Gan","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2026.115305_bb0115","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.3346\/jkms.2015.30.12.1856","article-title":"The toxicity of nonsteroidal anti-inflammatory eye drops against human corneal epithelial cells in vitro","volume":"30","author":"Lee","year":"2015","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.jconrel.2026.115305_bb0120","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.3390\/cells11162549","article-title":"Corneal regeneration using adipose-derived mesenchymal stem cells","volume":"11","author":"Ali\u00f3 del Barrio","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.115305_bb0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2015.03.002","article-title":"Engineering mesenchymal stem cells for regenerative medicine and drug delivery","volume":"84","author":"Park","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.jconrel.2026.115305_bb0130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2018.12.019","article-title":"Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic","volume":"294","author":"Wu","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115305_bb0135","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2014.10.015","article-title":"Nano-engineered mesenchymal stem cells as targeted therapeutic carriers","volume":"196","author":"Sadhukha","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115305_bb0140","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1021\/nn202399w","article-title":"Silica nanorattle\u2013doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy","volume":"5","author":"Li","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115305_bb0145","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1158\/1535-7163.MCT-17-0682","article-title":"Nano-engineered mesenchymal stem cells increase therapeutic efficacy of anticancer drug through true active tumor targeting","volume":"17","author":"Layek","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2026.115305_bb0150","article-title":"Inflammation-targeting mesenchymal stem cells combined with photothermal treatment attenuate severe joint inflammation","volume":"36","author":"Shin","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115305_bb0155","first-page":"438","article-title":"ROS-responsive nanoparticle delivery of ferroptosis inhibitor prodrug to facilitate mesenchymal stem cell-mediated spinal cord injury repair","volume":"38","author":"Hua","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115305_bb0160","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1007\/s13346-025-01829-5","article-title":"Effects of beta and gamma radiation sterilization on growth factor-loaded nanoparticles: an innovative approach for osteoarticular disorders treatment","volume":"15","author":"Ordoyo-Pascual","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.115305_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117962","article-title":"Noninvasive ocular delivery of adalimumab-loaded nanostructured lipid carriers for targeted retinitis pigmentosa therapy","volume":"185","author":"Velasco","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2026.115305_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12035-017-0728-7","article-title":"Intranasal administration of TAT-conjugated lipid nanocarriers loading GDNF for Parkinson\u2019s disease","volume":"55","author":"Hernando","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jconrel.2026.115305_bb0175","first-page":"45","article-title":"Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles","volume":"62","author":"Rivolta","year":"2011","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115305_bb0180","first-page":"5261","article-title":"Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect","volume":"9","author":"Wu","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115305_bb0185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/mp500401t","article-title":"Cellular uptake of coumarin-6 under microfluidic conditions into HCE-T cells from nanoscale formulations","volume":"12","author":"Pretor","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115305_bb0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jconrel.2017.03.386","article-title":"Retinal gene delivery enhancement by lycopene incorporation into cationic niosomes based on DOTMA and polysorbate 60","volume":"254","author":"Mashal","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115305_bb0195","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/chromsci\/bmw022","article-title":"Stability-indicating RP-HPLC methods for the determination of fluorometholone in its mixtures with sodium cromoglycate and tetrahydrozoline hydrochloride","volume":"54","author":"El-Bagary","year":"2016","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jconrel.2026.115305_bb0200","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jconrel.2026.115305_bb0205","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jcyt.2013.02.006","volume":"15","author":"Bourin","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jconrel.2026.115305_bb0210","first-page":"614","article-title":"An SV40-immortalized human corneal epithelial cell line and its characterization","volume":"36","author":"Araki-Sasaki","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2026.115305_bb0215","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.addr.2006.07.022","article-title":"Industrial perspective in ocular drug delivery","volume":"58","author":"Ali","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115305_bb0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature01451","article-title":"Regulated portals of entry into the cell","volume":"422","author":"Conner","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115305_bb0225","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.addr.2003.12.002","article-title":"Solid lipid nanoparticles for parenteral drug delivery","volume":"56","author":"Wissing","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115305_bb0230","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0939-6411(98)00074-5","article-title":"Correlation between long-term stability of solid lipid nanoparticles (SLN(TM)) and crystallinity of the lipid phase","volume":"47","author":"Freitas","year":"1999","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2026.115305_bb0235","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115305_bb0240","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/187221013804484827","article-title":"Nanostructured lipid carriers (NLCs) for drug delivery and targeting","volume":"7","author":"Fang","year":"2013","journal-title":"Recent Pat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115305_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/DDC-120001481","article-title":"Nanoparticle technology for drug delivery across the blood-brain barrier","volume":"28","author":"Lockman","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2026.115305_bb0250","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1096\/fj.05-4288fje","article-title":"Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking","volume":"19","author":"Huang","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2026.115305_bb0255","doi-asserted-by":"crossref","first-page":"8393","DOI":"10.1016\/j.biomaterials.2010.07.048","article-title":"Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors","volume":"31","author":"Roger","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115305_bb0260","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3109\/10837450.2015.1089897","article-title":"Modified NLC-loaded coumarin for pharmaceutical applications: the improvement of physical stability and controlled release profile","volume":"21","author":"Iemsam-Arng","year":"2016","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2026.115305_bb0265","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.toxrep.2015.03.004","article-title":"Short-term changes in intracellular ROS localisation after the silver nanoparticles exposure depending on particle size","volume":"2","author":"Onodera","year":"2015","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.jconrel.2026.115305_bb0270","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3109\/02713683.2013.802809","article-title":"In vitro simulation of corneal epithelium microenvironment induces a corneal epithelial-like cell phenotype from human adipose tissue mesenchymal stem cells","volume":"38","author":"Nieto-Miguel","year":"2013","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2026.115305_bb0275","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1093\/ndt\/13.10.2450","article-title":"The antiproliferative effect of glucocorticoids: is it related to induction of TGF-\u03b2?","volume":"13","author":"Almawi","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jconrel.2026.115305_bb0280","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/scd.2018.0183","article-title":"Mesenchymal stromal cells derived from normal cervix and cervical cancer tumors increase CD73 expression in cervical cancer cells through TGF-\u03b21 production","volume":"28","author":"\u00c1vila-Ibarra","year":"2019","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.jconrel.2026.115305_bb0285","doi-asserted-by":"crossref","first-page":"43799","DOI":"10.1074\/jbc.M207160200","article-title":"Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-\u03b2 pathways","volume":"277","author":"S\u00e1nchez-Elsner","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.115305_bb0290","doi-asserted-by":"crossref","first-page":"19027","DOI":"10.1016\/S0021-9258(18)41732-2","article-title":"Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells","volume":"267","author":"Cheifetz","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.115305_bb0295","first-page":"1","article-title":"CD73 expression on mesenchymal stem cells dictates the reparative properties via its anti-inflammatory activity","volume":"2019","author":"Tan","year":"2019","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.jconrel.2026.115305_bb0300","doi-asserted-by":"crossref","DOI":"10.1186\/scrt226","article-title":"Characterization of corneal stromal stem cells with the potential for epithelial transdifferentiation","volume":"4","author":"Hashmani","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.jconrel.2026.115305_bb0305","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40824-018-0141-y","article-title":"Nanoengineered, cell-derived extracellular matrix influences ECM-related gene expression of mesenchymal stem cells","volume":"22","author":"Ozguldez","year":"2018","journal-title":"Biomater. Res."},{"key":"10.1016\/j.jconrel.2026.115305_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114389","article-title":"Aging and autophagic phenotypic changes in bone marrow mesenchymal stem cells in glucocorticoid-induced osteonecrosis","volume":"152","author":"Cao","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2026.115305_bb0315","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s11658-016-0016-y","article-title":"In vitro chondrogenesis of Wharton\u2019s jelly mesenchymal stem cells in hyaluronic acid-based hydrogels","volume":"21","author":"Aleksander-Konert","year":"2016","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.jconrel.2026.115305_bb0320","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/jbm.b.30721","article-title":"Hydrogel-filled polylactide porous scaffolds for cartilage tissue engineering","volume":"82","author":"Gong","year":"2007","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.jconrel.2026.115305_bb0325","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3762\/bjnano.8.123","article-title":"Nano-engineered skin mesenchymal stem cells: potential vehicles for tumour-targeted quantum-dot delivery","volume":"8","author":"Saulite","year":"2017","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115305_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11040491","article-title":"Improving payload capacity and anti-tumor efficacy of mesenchymal stem cells using TAT peptide functionalized polymeric nanoparticles","volume":"11","author":"Moku","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2026.115305_bb0335","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1080\/10717544.2017.1375580","article-title":"Maximized nanodrug-loaded mesenchymal stem cells by a dual drug-loaded mode for the systemic treatment of metastatic lung cancer","volume":"24","author":"Yao","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115305_bb0340","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1734-1140(12)70901-5","article-title":"Nanoparticles as drug delivery systems","volume":"64","author":"Wilczewska","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jconrel.2026.115305_bb0345","article-title":"Organelle-targeted nanostructured lipid carriers: strategic design, analytical validation, and translational insights for precision intracellular drug delivery","volume":"114","author":"Sadiq","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.115305_bb0350","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/s41467-022-29679-6","article-title":"Dissecting extracellular and intracellular distribution of nanoparticles and their contribution to therapeutic response by monochromatic ratiometric imaging","volume":"13","author":"Yan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115305_bb0355","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1038\/s41598-024-54697-3","article-title":"Probing delivery of a lipid nanoparticle encapsulated self-amplifying mRNA vaccine using coherent Raman microscopy and multiphoton imaging","volume":"14","author":"Bera","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115305_bb0360","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41565-023-01585-y","article-title":"Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona dependent","volume":"19","author":"Liam-Or","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115305_bb0365","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nprot.2014.002","article-title":"Engineering cells with intracellular agent\u2013loaded microparticles to control cell phenotype","volume":"9","author":"Ankrum","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2026.115305_bb0370","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1007\/s13346-024-01591-0","article-title":"Cell-mediated nanoparticle delivery systems: towards precision nanomedicine","volume":"14","author":"Cheng","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.115305_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176639","article-title":"Corticosteroids effects on LPS-induced rat inflammatory keratocyte cell model","volume":"12","author":"Yan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.115305_bb0380","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exer.2016.08.020","article-title":"Glucocorticoid action in human corneal epithelial cells establishes roles for corticosteroids in wound healing and barrier function of the eye","volume":"152","author":"Kadmiel","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2026.115305_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.886754","article-title":"Glucocorticoids preferentially influence expression of nucleoskeletal actin network and cell adhesive proteins in human trabecular meshwork cells","volume":"10","author":"Bachman","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2026.115305_bb0390","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.bbrc.2017.09.100","article-title":"SDF-1 improves wound healing ability of glucocorticoid-treated adipose tissue-derived mesenchymal stem cells","volume":"493","author":"Kato","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2026.115305_bb0395","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13287-020-02071-1","article-title":"Glucocorticoid guides mobilization of bone marrow stem\/progenitor cells via FPR and CXCR4 coupling","volume":"12","author":"Gao","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.jconrel.2026.115305_bb0400","doi-asserted-by":"crossref","DOI":"10.1111\/aos.17255","article-title":"Genetically modified mesenchymal stem cells with CXCR4 and TSG-6 as future cell therapy for the ocular surface: in vitro study of the cell migration and the regenerative capacity in an inflammation model","volume":"103","author":"Figueroa-Haro","year":"2025","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jconrel.2026.115305_bb0405","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1586\/1744666X.4.4.457","article-title":"Cytokines and chemokines in immune-based ocular surface inflammation","volume":"4","author":"Enr\u00edquez-de-Salamanca","year":"2008","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jconrel.2026.115305_bb0410","first-page":"862","article-title":"Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease","volume":"16","author":"Enr\u00edquez-de-Salamanca","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.jconrel.2026.115305_bb0415","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1167\/iovs.15-16595","article-title":"Quercetin and resveratrol decrease the inflammatory and oxidative responses in human ocular surface epithelial cells","volume":"56","author":"Abeng\u00f3zar-Vela","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2026.115305_bb0420","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pathophys.2017.05.005","article-title":"Interleukin-6 participation in pathology of ocular diseases","volume":"24","author":"Zahir-Jouzdani","year":"2017","journal-title":"Pathophysiology"},{"key":"10.1016\/j.jconrel.2026.115305_bb0425","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3390\/cells9051145","article-title":"Identifying the therapeutic significance of mesenchymal stem cells","volume":"9","author":"Mishra","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.115305_bb0430","doi-asserted-by":"crossref","first-page":"9531","DOI":"10.3390\/ijms22179531","article-title":"TNF-\u03b1 and IFN-\u03b3 participate in improving the immunoregulatory capacity of mesenchymal stem\/stromal cells: importance of cell\u2013cell contact and extracellular vesicles","volume":"22","author":"L\u00f3pez-Garc\u00eda","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115305_bb0435","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.joca.2012.06.003","article-title":"Mesenchymal stem cells secrete factors that inhibit inflammatory processes in short-term osteoarthritic synovium and cartilage explant culture","volume":"20","author":"van Buul","year":"2012","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jconrel.2026.115305_bb0440","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/term.3274","article-title":"Development and evaluation of IL-6 overexpressing mesenchymal stem cells (MSCs)","volume":"16","author":"Huang","year":"2022","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.jconrel.2026.115305_bb0445","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/jid.2011.64","article-title":"Tumor necrosis factor-\u03b1-activated human adipose tissue-derived mesenchymal stem cells accelerate cutaneous wound healing through paracrine mechanisms","volume":"131","author":"Heo","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115305_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101841","article-title":"Immunomodulatory effects of bone marrow-derived mesenchymal stem cells on pro-inflammatory cytokine-stimulated human corneal epithelial cells","volume":"9","author":"Wen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.115305_bb0455","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cytogfr.2009.10.002","article-title":"Mechanisms involved in the therapeutic properties of mesenchymal stem cells","volume":"20","author":"da Silva Meirelles","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jconrel.2026.115305_bb0460","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.exer.2012.11.017","article-title":"Effect of TGF-\u03b2 on ocular surface epithelial cells","volume":"107","author":"Benito","year":"2013","journal-title":"Exp. Eye Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:21:33Z","timestamp":1793337693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926007091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":92,"alternative-id":["S0168365926007091"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115305","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nano-engineered mesenchymal stem cells as a platform for targeted and biologically regulated drug delivery in ocular surface inflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115305"}}